These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Bidentates versus monodentates in asymmetric hydrogenation catalysis: synergic effects on rate and allosteric effects on enantioselectivity.
    Author: Norman DW, Carraz CA, Hyett DJ, Pringle PG, Sweeney JB, Orpen AG, Phetmung H, Wingad RL.
    Journal: J Am Chem Soc; 2008 May 28; 130(21):6840-7. PubMed ID: 18454526.
    Abstract:
    C 1-Symmetric phosphino/phosphonite ligands are prepared by the reactions of Ph 2P(CH 2) 2P(NMe 2) 2 with ( S)-1,1'-bi-2-naphthol (to give L A ) or ( S)-10,10'-bi-9-phenanthrol (to give L B ). Racemic 10,10'-bi-9-phenanthrol is synthesized in three steps from phenanthrene in 44% overall yield. The complexes [PdCl 2( L A,B )] ( 1a, b), [PtCl 2( L A,B )] ( 2a, b), [Rh(cod)( L A,B )]BF 4 ( 3a, b) and [Rh( L A,B ) 2]BF 4 ( 4a, b) are reported and the crystal structure of 1a has been determined. A (31)P NMR study shows that M, a 1:1 mixture of the monodentates, PMePh 2 and methyl monophosphonite L 1a (based on ( S)-1,1 '-bi-2-naphthol), reacts with 1 equiv of [Rh(cod) 2]BF 4 to give the heteroligand complex [Rh(cod)(PMePh 2)( L 1a )]BF 4 ( 5) and homoligand complexes [Rh(cod)(PMePh 2) 2]BF 4 ( 6) and [Rh(cod)( L 1a ) 2]BF 4 ( 7) in the ratio 2:1:1. The same mixture of 5- 7 is obtained upon mixing the isolated homoligand complexes 6 and 7 although the equilibrium is only established rapidly in the presence of an excess of PMePh 2. The predominant species 5 is a monodentate ligand complex analogue of the chelate 3a. When the mixture of 5- 7 is exposed to 5 atm H 2 for 1 h (the conditions used for catalyst preactivation in the asymmetric hydrogenation studies), the products are identified as the solvento species [Rh(PMePh 2)( L 1a )(S) 2]BF 4 ( 5'), [Rh(S) 2(PMePh 2) 2]BF 4 ( 6') and [Rh(S) 2( L 1a ) 2]BF 4 ( 7') and are formed in the same 2:1:1 ratio. The reaction of M with 0.5 equiv of [Rh(cod) 2]BF 4 gives exclusively the heteroligand complex cis-[Rh(PMePh 2) 2( L 1a ) 2]BF 4 ( 8), an analogue of 4a. The asymmetric hydrogenation of dehydroamino acid derivatives catalyzed by 3a, b is reported, and the enantioselectivities are compared with those obtained with (a) chelate catalysts derived from analogous diphosphonite ligands L 2a and L 2b , (b) catalysts based on methyl monophosphonites L 1a and L 1b , and (c) catalysts derived from mixture M. For the cinnamate and acrylate substrates studied, the catalysts derived from the phosphino/phosphonite bidentates L A,B generally give superior enantioselectivities to the analogous diphosphonites L 2a and L 2b ; these results are rationalized in terms of delta/lambda-chelate conformations and allosteric effects of the substrates. The rate of hydrogenation of acrylate substrate A with heterochelate 3a is significantly faster than with the homochelate analogues [Rh( L 2a )(cod)]BF 4 and [Rh(dppe)(cod)]BF 4. A synergic effect on the rate is also observed with the monodentate analogues: the rate of hydrogenation with the mixture containing predominantly heteroligand complex 5 is faster than with the monophosphine complex 6 or monophosphonite complex 7. Thus the hydrogenation catalysis carried out with M and [Rh(cod) 2]BF 4 is controlled by the dominant and most efficient heteroligand complex 5. In this study, the heterodiphos chelate 3a is shown to be more efficient and gives the opposite sense of optical induction to the heteromonophos analogue 5.
    [Abstract] [Full Text] [Related] [New Search]